NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.09 Million USD | -36.85% |
| 2022 | 12.82 Million USD | 61.52% |
| 2021 | 7.93 Million USD | 66.78% |
| 2020 | 4.75 Million USD | 793.66% |
| 2019 | 532.61 Thousand USD | 143.52% |
| 2018 | 218.71 Thousand USD | -12.51% |
| 2017 | 249.98 Thousand USD | -66.97% |
| 2016 | 756.93 Thousand USD | 41082.26% |
| 2015 | 1838.00 USD | 796.59% |
| 2014 | 205.00 USD | -60.95% |
| 2013 | 525.00 USD | -53.04% |
| 2012 | 1118.00 USD | -91.93% |
| 2011 | 13.85 Thousand USD | 51.73% |
| 2010 | 9129.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.39 Million USD | -7.34% |
| 2024 Q3 | 4.91 Million USD | -8.94% |
| 2024 Q1 | 5.82 Million USD | -28.09% |
| 2023 Q3 | 5.75 Million USD | -20.08% |
| 2023 Q4 | 8.09 Million USD | 40.62% |
| 2023 FY | 8.09 Million USD | -36.85% |
| 2023 Q1 | 9.66 Million USD | -24.66% |
| 2023 Q2 | 7.2 Million USD | -25.41% |
| 2022 FY | 12.82 Million USD | 61.52% |
| 2022 Q1 | 17.18 Million USD | 116.46% |
| 2022 Q4 | 12.82 Million USD | 10.82% |
| 2022 Q3 | 11.57 Million USD | -17.87% |
| 2022 Q2 | 14.08 Million USD | -18.01% |
| 2021 Q3 | 9.8 Million USD | -17.69% |
| 2021 Q1 | 7.91 Million USD | 66.25% |
| 2021 Q2 | 11.91 Million USD | 50.6% |
| 2021 FY | 7.93 Million USD | 66.78% |
| 2021 Q4 | 7.93 Million USD | -19.07% |
| 2020 Q4 | 4.75 Million USD | 6.66% |
| 2020 Q1 | 2.65 Million USD | 399.21% |
| 2020 Q2 | 1.38 Million USD | -47.75% |
| 2020 FY | 4.75 Million USD | 793.66% |
| 2020 Q3 | 4.46 Million USD | 221.22% |
| 2019 Q4 | 532.61 Thousand USD | -65.33% |
| 2019 Q3 | 1.53 Million USD | -40.34% |
| 2019 Q1 | 577.53 Thousand USD | 164.05% |
| 2019 Q2 | 2.57 Million USD | 345.83% |
| 2019 FY | 532.61 Thousand USD | 143.52% |
| 2018 FY | 218.71 Thousand USD | -12.51% |
| 2018 Q4 | 218.71 Thousand USD | -4.78% |
| 2018 Q3 | 229.69 Thousand USD | -5.77% |
| 2018 Q2 | 243.76 Thousand USD | -2.49% |
| 2018 Q1 | 249.98 Thousand USD | -6.66% |
| 2017 Q1 | 756.93 Thousand USD | 17597.69% |
| 2017 Q2 | 662.3 Thousand USD | -12.5% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q4 | 267.81 Thousand USD | 0.0% |
| 2017 FY | 249.98 Thousand USD | -66.97% |
| 2016 Q1 | 1838.00 USD | 814.43% |
| 2016 FY | 756.93 Thousand USD | 41082.26% |
| 2016 Q4 | 4277.00 USD | 0.0% |
| 2016 Q3 | 4277.00 USD | 135.52% |
| 2016 Q2 | 1816.00 USD | -1.2% |
| 2015 FY | 1838.00 USD | 796.59% |
| 2015 Q2 | 195.00 USD | -4.88% |
| 2015 Q4 | 201.00 USD | -45.82% |
| 2015 Q3 | 371.00 USD | 90.26% |
| 2015 Q1 | 205.00 USD | -65.78% |
| 2014 Q2 | 500.00 USD | -4.76% |
| 2014 Q1 | 525.00 USD | -13.65% |
| 2014 FY | 205.00 USD | -60.95% |
| 2014 Q4 | 599.00 USD | -11.91% |
| 2014 Q3 | 680.00 USD | 36.0% |
| 2013 Q4 | 608.00 USD | -54.56% |
| 2013 FY | 525.00 USD | -53.04% |
| 2013 Q2 | 5133.00 USD | 359.12% |
| 2013 Q1 | 1118.00 USD | -24.71% |
| 2013 Q3 | 1338.00 USD | -73.93% |
| 2012 FY | 1118.00 USD | -91.93% |
| 2012 Q3 | 6046.00 USD | -27.44% |
| 2012 Q4 | 1485.00 USD | -75.44% |
| 2012 Q2 | 8332.00 USD | -39.85% |
| 2012 Q1 | 13.85 Thousand USD | 182.16% |
| 2011 Q1 | 9129.00 USD | 0.0% |
| 2011 FY | 13.85 Thousand USD | 51.73% |
| 2011 Q4 | 4909.00 USD | 2.59% |
| 2011 Q3 | 4785.00 USD | 0.0% |
| 2010 FY | 9129.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acutus Medical, Inc. | 53.96 Million USD | 84.994% |
| Cerus Corporation | 197.74 Million USD | 95.905% |
| OrthoPediatrics Corp. | 449.58 Million USD | 98.199% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -159.925% |
| Talis Biomedical Corporation | 98.34 Million USD | 91.766% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 24.536% |
| Inogen, Inc. | 326.19 Million USD | 97.518% |
| Spectral AI, Inc. | 10.69 Million USD | 24.268% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 96.297% |
| CVRx, Inc. | 115.22 Million USD | 92.973% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 86.196% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -5.269% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.125% |
| Venus Concept Inc. | 93.65 Million USD | 91.354% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 74.184% |
| Bioventus Inc. | 810.91 Million USD | 99.001% |
| BrainsWay Ltd. | 62.97 Million USD | 87.141% |
| Envoy Medical, Inc. | 7.64 Million USD | -5.986% |
| electroCore, Inc. | 16.38 Million USD | 50.587% |
| IceCure Medical Ltd | 16.41 Million USD | 50.656% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 70.307% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 51.159% |
| MaxCyte, Inc. | 268.27 Million USD | 96.982% |
| Nexalin Technology, Inc. | 3.63 Million USD | -122.949% |
| PAVmed Inc | 33.11 Million USD | 75.551% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 94.355% |
| RxSight, Inc. | 182.55 Million USD | 95.564% |
| Sight Sciences, Inc. | 166.65 Million USD | 95.141% |
| SI-BONE, Inc. | 230.42 Million USD | 96.486% |
| TELA Bio, Inc. | 78.04 Million USD | 89.625% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 68.524% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 96.786% |
| LivaNova PLC | 2.42 Billion USD | 99.667% |
| 908 Devices Inc. | 202.98 Million USD | 96.011% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.994% |
| Nemaura Medical Inc. | 14.56 Million USD | 44.399% |
| NeuroPace, Inc. | 107.65 Million USD | 92.478% |
| LENSAR, Inc. | 69.58 Million USD | 88.363% |
| Apyx Medical Corporation | 79.24 Million USD | 89.781% |
| Cutera, Inc. | 346.29 Million USD | 97.662% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 80.728% |
| BioSig Technologies, Inc. | 1.79 Million USD | -350.351% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 97.008% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 81.019% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.786% |
| Axonics, Inc. | 719.92 Million USD | 98.875% |
| Outset Medical, Inc. | 313.8 Million USD | 97.42% |
| IRIDEX Corporation | 34.43 Million USD | 76.486% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.999% |
| IRadimed Corporation | 92.15 Million USD | 91.213% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -54.117% |
| INVO Bioscience, Inc. | 20.88 Million USD | 61.234% |
| Telesis Bio, Inc. | 70.41 Million USD | 88.5% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 94.746% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.352% |
| Quipt Home Medical Corp. | 247.4 Million USD | 96.727% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 13.026% |
| Pulmonx Corporation | 178.95 Million USD | 95.475% |
| Dynatronics Corporation | 25.94 Million USD | 68.785% |
| Modular Medical, Inc. | 13.8 Million USD | 41.354% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 24.515% |
| Semler Scientific, Inc. | 78.06 Million USD | 89.627% |
| InMode Ltd. | 863.28 Million USD | 99.062% |
| Bruker Corporation | 4.24 Billion USD | 99.809% |
| Cytosorbents Corporation | 53.26 Million USD | 84.797% |
| DexCom, Inc. | 6.26 Billion USD | 99.871% |
| Align Technology, Inc. | 6.08 Billion USD | 99.867% |
| Viveve Medical, Inc. | 25.91 Million USD | 68.752% |
| ZimVie Inc. | 1.2 Billion USD | 99.328% |
| Movano Inc. | 9.42 Million USD | 14.05% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.373% |
| Nexalin Technology, Inc. | 3.63 Million USD | -122.949% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 86.196% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.15% |
| Profound Medical Corp. | 43.68 Million USD | 81.465% |
| Insulet Corporation | 2.58 Billion USD | 99.687% |
| enVVeno Medical Corporation | 48.63 Million USD | 83.351% |
| Surmodics, Inc. | 185.73 Million USD | 95.64% |
| iCAD, Inc. | 41.41 Million USD | 80.45% |
| Nuwellis, Inc. | 9.77 Million USD | 17.121% |
| Biotricity, Inc. | 5.94 Million USD | -36.258% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 98.131% |
| Aethlon Medical, Inc. | 8.24 Million USD | 1.803% |
| InspireMD, Inc. | 47.64 Million USD | 83.004% |
| PAVmed Inc. | 33.11 Million USD | 75.551% |
| BIOLASE, Inc. | 35.1 Million USD | 76.931% |
| Beyond Air, Inc. | 56.96 Million USD | 85.784% |
| FONAR Corporation | 214.24 Million USD | 96.221% |
| AxoGen, Inc. | 196.82 Million USD | 95.886% |
| Vivani Medical, Inc. | 45.79 Million USD | 82.319% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 97.123% |
| Inari Medical, Inc. | 674.23 Million USD | 98.799% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.996% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 65.394% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 14.793% |
| Tenon Medical, Inc. | 6.34 Million USD | -27.617% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 13.922% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 92.188% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.825% |
| Sintx Technologies, Inc. | 15.36 Million USD | 47.3% |
| NanoVibronix, Inc. | 6.67 Million USD | -21.326% |
| Quanterix Corporation | 425.01 Million USD | 98.095% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 13.026% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 84.929% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.536% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.853% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 87.186% |
| NeuroMetrix, Inc. | 21.42 Million USD | 62.205% |
| Hyperfine, Inc. | 94.19 Million USD | 91.404% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.986% |
| Biomerica, Inc. | 9.25 Million USD | 12.499% |
| Bone Biologics Corporation | 3.73 Million USD | -116.635% |
| AVITA Medical, Inc. | 144.33 Million USD | 94.39% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -66.319% |
| Silk Road Medical, Inc | 265.3 Million USD | 96.948% |